CORONAVIRUS

Moderna Virus Vaccine Shows Overwhelming Success In US Tests

Nov 16, 2020, 8:23 AM
FILE (Photo by Joe Raedle/Getty Images)...
FILE (Photo by Joe Raedle/Getty Images)
(Photo by Joe Raedle/Getty Images)

Moderna said Monday its COVID-19 vaccine is proving to be highly effective in a major trial, a second dash of hope in the global race for a shot to tame a resurgent virus that is now killing more than 8,000 people a day worldwide.

The company said its vaccine appears to be 94.5% effective, according to preliminary data from Moderna’s ongoing study. A week ago, competitor Pfizer Inc. announced its own COVID-19 vaccine appeared similarly effective — news that puts both companies on track to seek permission within weeks for emergency use in the U.S.

The results are “truly striking,” said Dr. Anthony Fauci, the U.S. government’s top infectious diseases expert. Earlier this year, Fauci said he would be happy with a COVID-19 vaccine that was 60% effective.

A vaccine can’t come fast enough, as virus cases topped 11 million in the U.S. over the weekend — 1 million of them recorded in just the past week — and governors and mayors are ratcheting up restrictions ahead of Thanksgiving. The pandemic has killed more than 1.3 million people worldwide, over 245,000 of them in the U.S.

Dr. Stephen Hoge, Moderna’s president, welcomed the “really important milestone” but said having similar results from two different companies is what’s most reassuring.

“That should give us all hope that actually a vaccine is going to be able to stop this pandemic and hopefully get us back to our lives,” Hoge told The Associated Press. He added: “It won’t be Moderna alone that solves this problem. It’s going to require many vaccines” to meet the global demand.

The National Institutes of Health helped create the vaccine Moderna is manufacturing, and NIH’s director, Dr. Francis Collins, said the exciting news from two companies “gives us a lot of confidence that we’re on the path towards having effective vaccines.”

But “we’re also at this really dark time,” he warned, saying people can’t let down their guard during the months it will take for doses of any vaccines cleared by the Food and Drug Administration to start reaching a large share of the population.

If the FDA allows emergency use of Moderna’s or Pfizer’s candidate, there will be limited, rationed supplies before the end of the year.

Both vaccines require people to get two shots, several weeks apart. U.S. officials said they hope to have about 20 million Moderna doses and another 20 million doses of the vaccine made by Pfizer and its German partner BioNTech to use in late December.

Exactly who is first in line is yet to be decided. But Health and Human Services Secretary Alex Azar said the hope is that enough doses are available by the end of January to vaccinate adults over 65, who are at the highest risk from the coronavirus, and health care workers. Fauci said it may take until spring or summer for enough for anyone who is not high risk and wants a shot to get one.

Another important message: Additional vaccines that work in different ways are still in testing — and despite the promising news about Moderna’s and Pfizer’s shots, more volunteers are needed for those studies.

Stocks opened higher on the news on Wall Street. Moderna was likely to hit an all-time high. Markets in Asia and Europe were up sharply as well.

Moderna’s vaccine is being studied in 30,000 volunteers who received either the real thing or a dummy shot. On Sunday, an independent monitoring board examined 95 infections that were recorded after volunteers’ second dose, and they discovered all but five illnesses occurred in participants who got the placebo.

The study is continuing, and Moderna acknowledged the protection rate might change as more COVID-19 infections are detected. Also, it’s too soon to know how long protection lasts. Both cautions apply to Pfizer’s vaccine as well.

But Moderna’s independent monitors reported some additional, promising tidbits: All 11 severe COVID-19 cases were among placebo recipients, and there were no significant safety concerns. The main side effects were fatigue, muscle aches and injection-site pain after the second dose.

The Cambridge, Massachusetts, company’s vaccine is among 11 candidates in late-stage testing around the world, four of them in huge studies in the U.S.

Both Moderna’s shots and the Pfizer-BioNTech candidate are so-called mRNA vaccines, a brand-new technology. They aren’t made with the coronavirus itself, meaning there’s no chance anyone could catch it from the shots. Instead, the vaccine contains a piece of genetic code that trains the immune system to recognize the spiked protein on the surface of the virus.

Another steep challenge: distributing doses that must be kept very cold. Both the Moderna and Pfizer shots are frozen but at different temperatures. Moderna said that once thawed, its doses can last longer in a refrigerator than initially thought, up to 30 days. Pfizer’s shots require long-term storage at ultra-cold temperatures.

Pfizer CEO Albert Bourla tweeted that that he was thrilled at Moderna’s news, saying, “Our companies share a common goal — defeating this dreaded disease.”

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

KSL 5 TV Live

Top Stories

Coronavirus

FILE: Relatives of Elba Pabay hold a picture of her as people who've lost loved ones due to COVID-1...
CARLA K. JOHNSON, AP Medical Writer

US deaths from COVID hit 1 million, less than 2 1/2 years in

The U.S. death toll from COVID-19 has hit 1 million, less than 2 1/2 years into the outbreak.
10 hours ago
FILE: North Koraen Leader Kim Jong Un  (Photo by Korea Summit Press Pool/Getty Images)...
KIM TONG-HYUNG, Associated Press

Kim blasts pandemic response as North Korean outbreak surges

North Korean leader Kim Jong Un blasted officials over slow COVID-19 vaccine deliveries that has left 1.2 million people ill with fever and 50 dead in a matter of days.
1 day ago
FILE: Pfizer-BioNTech COVID-19 (left) and Moderna COVID-19 (right) vaccines are seen at a vaccinati...
Matt Rascon, KSL TV

Vaccinated make up nearly 39% of omicron deaths in Utah

Since the availability of the vaccine, those without a shot have made up the greatest portion of people who have died from COVID. That hasn’t changed. But since the start of the omicron variant, the percentage of vaccinated people who are dying has gone up significantly.
3 days ago
A mobile team with the Salt Lake County Health Department administers COVID-19 vaccines at Rancho M...
Ken Fall, KSL TV

Are you over 50 or heading out of town? Get a 2nd COVID-19 booster, Utah doctor says

With COVID-19 rates rising in Utah and throughout most of the country, public health officials are most concerned about people over 50 and the immunocompromised. 
4 days ago
(KSL TV)...
Josh Ellis, KSL TV

Going cashless during COVID-19 pandemic was ‘useless,’ BYU study says

Efforts to slow the spread of COVID-19 by going cashless were essentially useless, according to a new study from Brigham Young University.
4 days ago
The U.S. flag flies at half staff over the U.S. Capitol Building in Washington, DC on May 12, 2022 ...
Madison Swenson, KSL TV

Gov. Cox orders flags to be lowered in honor of COVID victims

Gov. Spencer Cox has ordered flags at all state facilities to be lowered for the next few days in accordance with President Joe Biden's proclamation honoring the 1,000,000 people who have lost their lives to COVID-19.
4 days ago

Sponsored Articles

Earth day 2022...
1-800-GOT-JUNK?

How Are You Celebrating Earth Day 2022? | 4 Simple Ways to Celebrate Earth Day and Protect the Environment

Earth Day is a great time to reflect on how we can be more environmentally conscious. Here are some tips for celebrating Earth Day.
Get Money Online...

More Ways to Get Money Online Right Now in Your Spare Time

Here are 4 easy ways that you can get more money online if you have some free time and want to make a little extra on the side.
Lighting trends 2022...

Lighting Trends 2022 | 5 Beautiful Home Lighting Trends You Can Expect to See this Year and Beyond

This is where you can see the latest lighting trends for 2022 straight from the Lightovation Show at the Dallas World Trade Center.
What Can't You Throw Away in the Trash...

What Can’t You Throw Away in the Trash? | 5 Things You Shouldn’t Throw in to Your Trash Can

What can't you throw away in the trash? Believe it or not, there are actually many items that shouldn't be thrown straight into the trash.
Make Money Online Easily...

4 Ways that You Can Make Money Online Easily in Just a Few Clicks

Here are 4 ways that you can make money online easily in no time at all! Some are as simple as just a few clicks away.
tips to winterize your home...
Bonneville Digital SLC

Tips to Winterize Your Home | The Top 5 Ways You Can Prepare for the Cold Utah Winter Ahead

Before the snow hits, here are the top 5 tips to winterize your home to prepare for the cold Utah winter this year.
Moderna Virus Vaccine Shows Overwhelming Success In US Tests